Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
Status:
NOT_YET_RECRUITING
Trial end date:
2035-03-31
Target enrollment:
Participant gender:
Summary
This study investigates whether adding magnesium to the standard chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC) can improve treatment outcomes. Magnesium is important for immune function, and low levels during chemotherapy are common. Participants are randomly assigned to receive either magnesium or a placebo, both as infusions and tablets. Neither the participants nor the doctors know who receives which treatment. The study compares the two groups to see if magnesium helps and how well it is tolerated.